See this before the rush for the exits begins

The quantum complex has been punished. Over the past 30 days, IonQ shares plunged 31.7%, D-Wave declined 35.7%, Rigetti lost 28%, and QUBT fell 21.3%. Then, last Thursday, all three fell another 8% with no company-specific news to explain it. These are not stocks that move on fundamentals quarter to quarter. They move on sentiment, and right now sentiment has cracked.

Tonight and tomorrow morning, that changes. Rigetti reports its third-quarter 2026 results after the close on November 10. D-Wave reports the same day before the market opens. Both releases arrive against a backdrop that creates the exact conditions where options discipline is non-negotiable: cheap-looking stock prices paired with options premiums that are still pricing in enormous moves.

The Beast: D-Wave’s Revenue Math

D-Wave is the more structurally interesting problem. The company needs roughly $36.5 million in second-half revenue after posting about $5.9 million in the first six months, a steep ramp for a company that has missed revenue consensus in each of its last three quarters, with analysts projecting full-year 2026 sales of roughly $42 million. Management has been explicit about where that revenue comes from. Management has said the fourth quarter will deliver “the majority of the year’s total revenue,” a statement that puts enormous pressure on a single three-month window to validate the entire year.

Wall Street analysts expect about $32 million in Q4 revenue alone, a figure that represents more than five times the roughly $5.9 million D-Wave recognized across the entire first half of 2026. The Q3 report itself is not the point. Analysts expect D-Wave to post revenue of about $4.3 million for the quarter. What matters tonight is guidance: does management confirm Q4 system deliveries are on track? Analysts modeling recovery scenarios are banking on D-Wave delivering two quantum computing systems before year-end. Any language that casts doubt on timing will punish the stock regardless of what Q3 shows.

The valuation remains difficult to defend on current numbers. Forward consensus estimates still produce a valuation exceeding 100 times expected 2026 revenue and more than 50 times projected 2027 sales.

Rigetti’s Own Test

Rigetti’s challenge is different but equally binary. Rigetti’s second-quarter results showed revenue of $5.1 million, up about 183% year-over-year, while gross margin improved to 43% from 31%. However, the company’s net loss widened to $52.6 million from $39.7 million a year earlier.

Particular attention will be on the $8.4 million order from India’s Centre for Development of Advanced Computing (C-DAC) for a 108-qubit system, which management has said it plans to fulfill in the fourth quarter, with most of the revenue expected to be recognized upon installation and acceptance testing. That C-DAC order alone is worth more than twice Wall Street’s expected Q3 revenue of $3.67 million. Revenue recognition is everything here: strong bookings mean nothing until systems ship and customers accept delivery.

IonQ’s Beat Changes the Context

One reason Thursday’s sympathy bounce matters: IonQ has already reported, and the number was extraordinary. IonQ reported GAAP revenue of $173.8 million, up 336% year-over-year, marking its sixth consecutive record quarter. IonQ raised its 2026 revenue guidance to $505-$515 million from the $450-$460 million range. That beat lifted D-Wave and Rigetti 16-18% heading into their own results, compressing the entry window for anyone still trying to position.

Options Perspective

This is where defining risk before the event matters most. QBTS options were trading at a 30-day at-the-money implied volatility around the mid-90% range, with an IV rank in the mid-60s to low-70s, meaning implied volatility is elevated relative to its own 52-week range. With stocks that have already moved 16-19% higher into the report on IonQ sympathy, outright long calls carry meaningful premium risk. If D-Wave or Rigetti disappoint on guidance, that premium evaporates regardless of October’s lower starting prices.

A bull call spread on QBTS targeting a continued recovery through December, with a strike just above Friday’s close and an upper strike at a meaningful resistance level, keeps the debit finite while still participating in a Q4 guidance upgrade scenario. The same structure on RGTI makes sense if tonight’s report confirms the C-DAC delivery timeline. Both positions should be sized to reflect that these stocks have a demonstrated habit of moving 15-20% on earnings, in either direction.

The Beast Verdict

The asymmetric opportunity here is not in betting that quantum stocks are cheap. They are expensive on any near-term revenue metric. The edge is in recognizing that D-Wave and Rigetti’s results arrive at a moment when the sector’s AI-risk-appetite proxy has already re-rated sharply off October lows, options premiums remain elevated but not extreme, and a single credible Q4 guidance statement from D-Wave’s management could close a significant portion of the gap between a $10 stock and $33 analyst targets. The stock has shed about 70% from its 52-week high, declining from about $36 to around $10.65 over the past year, a collapse that analyst price targets have largely failed to track. That divergence either resolves through the targets coming down, or through D-Wave actually shipping systems. Tonight begins to answer which.

Define the risk. Watch the guidance language. The contracts are secondary.